PPT Slide

TTP: CR/CCR Patients

Kaplan-Meier AnalysisC = censored

C

0

10

20

30

40

50

60

70

80

90

100

Months

C

C

C

C

C

C

C

C

C

C

C

C

C

C

Progression Free (%)

p = 0.144Log-rank test

Zevalin (N = 15)

Rituximab (N = 11)

ODAC Presentation *

Previous slide

Next slide

Back to first slide

View graphic version